BRIACELL THERAPEUTICS CORP's ticker is BCTXW and the CUSIP is 10778Y112. A total of 9 filers reported holding BRIACELL THERAPEUTICS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $92,696 | -28.1% | 45,000 | 0.0% | 0.01% | -33.3% |
| Q3 2022 | $129,000 | +10.3% | 45,000 | 0.0% | 0.01% | +12.5% |
| Q2 2022 | $117,000 | -50.0% | 45,000 | 0.0% | 0.01% | -33.3% |
| Q1 2022 | $234,000 | +10.9% | 45,000 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $211,000 | -1.4% | 45,000 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $214,000 | +164.2% | 45,000 | 0.0% | 0.01% | +140.0% |
| Q2 2021 | $81,000 | +68.8% | 45,000 | 0.0% | 0.01% | +66.7% |
| Q1 2021 | $48,000 | – | 45,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Murchinson Ltd. | 469,950 | $2,444,000 | 0.47% |
| K.J. Harrison & Partners Inc | 160,057 | $832,000 | 0.13% |
| Redmond Asset Management, LLC | 75,000 | $390,000 | 0.12% |
| ARMISTICE CAPITAL, LLC | 375,000 | $1,950,000 | 0.04% |
| ZEKE CAPITAL ADVISORS, LLC | 45,000 | $234,000 | 0.01% |
| Warberg Asset Management LLC | 32,092 | $166,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 16,092 | $84,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 1,137 | $6,000 | 0.00% |